Eruption of Metastatic Paraganglioma After Successful Therapy with 177 Lu/ 90 Y-DOTATOC and 177 Lu-DOTATATE

• Published in: Nuclear medicine and molecular imaging Vol. 53; no. 3; p. 223
• Main Authors: Wolf, Katherine I, Jha, Abhishek, van Berkel, Anouk, Wild, Damian, Janssen, Ingo, Millo, Corina M, Janssen, M J R, Gonzales, Melissa K, Timmers, Henri J K M, Pacak, Karel
• Format: Journal Article
• Language: English
• Published: Germany 01.06.2019
• Subjects: 68Ga-DOTATATE; PRRT; Paraganglioma; SSTR; 177Lu-DOTATATE; 18F-FDG

Metastatic paraganglioma treatment options are limited. Peptide receptor radionuclide therapy (PRRT) has been introduced as a novel management option for metastatic neuroendocrine tumors demonstrating safety, efficacy, and increased quality of life. We present two cases of marked progression of meta...